Funding Opportunities

[ LSOs | Intramural Awards | Foundations/Other | NIH Announcements ]

Intramural Funding Opportunities

• Deadline: August 28
  DHART SPORE - Career Development Program (CDP) Awards [application]
  The goals of the CDP are (1) to attract outstanding young basic scientists and clinical investigators to the field of NF1-associated tumor research; (2) to assist in the career development of these junior faculty; and, (3) to encourage collaborations between investigators which can lead to new ideas and directions in research related to tumors associated with NF1 mutations and can contribute to career development.
• Deadline: August 28
  DHART SPORE - Developmental Research Program (DRP) Awards [application]
  The DRP supports innovative pilot projects to advance the diagnosis and treatment of early stage tumors and advanced cancers characterized by germline and somatic NF1 mutations. The DRP will accomplish this goal by funding rigorous translational research in the areas of population science, therapeutics, and mechanisms of disease and by facilitating collaborative interactions between DRP-funded scientists and other SPORE investigators.
• Deadline: September 18
  Resource Allocation Program - Fall 2017 Cycle [application]
  • Global Cancer Pilot Award
  • Pilot Award in Precision Imaging of Cancer and Therapy (PICT)
  • Integrative Cancer Pilot Awards
  • Pilot Award for Pancreas Cancer
  • Pilot for Established Investigators in Basic and Clinical/Translational Sciences
  • Pilot for Junior Investigators in Basic and Clinical/Translational Sciences
  • and many more...
     

Foundations/Other Sources

• Deadline: Ongoing
  Gateway for Cancer Research - Clinical Trials Funding Program [RFA]
  - View FAQs for Researchers
  - Submit LOIs through e-grant management website

• Deadline: August 20
  Cancer Cell Map Initiative's Cancer Systems Biology Pilot Project Program
  The Cancer Cell Map Initiative (CCMI; www.ccmi.org) has funds to support up to two pilot projects in cancer systems biology. Project proposals are solicited from faculty members at UCSF, UC San Diego and nearby universities and research institutes (within 30 miles of either campus) wishing to develop and apply systems biology approaches to address a compelling biomedical question in cancer in collaboration with CCMI investigators.
• LOI Due: August 21
  Tobacco-Related Disease Research Program (TRDRP) 2018 Funding Opportunities
  
  The TRDRP is currently offering 11 award types for applications that address one or more of TRDRP’s eight research priorities: (1) tobacco-related health disparities; (2) cancer prevention, treatment and biology; (3) cardiovascular and cerebrovascular diseases; (4) environmental exposure and toxicology; (5) neuroscience of nicotine addiction and treatment; (6) oral diseases and dental health; (7) pulmonary biology and lung diseases; and (8) state and local tobacco control policy research.
• LOI Due: September 5
  SU2C Dream Team Translational Research Grant
  This $10 million grant will fund a translational cancer research project that will address critical problems in patient care, including prevention strategies for those at risk, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, collaborative Dream Team of expert investigators. 
• Deadlines: September 14 (pre-submission form) and October 12 (expression of interest)
  Cancer Research UK Grand Challenge
  The Grand Challenge is intended to stimulate a focused multinational, interdisciplinary research effort to tackle significant problems in cancer research, bringing in new thinking, innovation, and technology from other disciplines and sectors. It is intended to drive global collaboration and support research that would not be able to happen without a team approach and funding on this scale. If you intend to apply, please alert the UCSF RDO (rdoinfo@ucsf.edu) so they can provide support and help to coordinate submissions.
• Deadline: October 16
  American Cancer Society RFA: Understanding, Preventing, and Managing Immunotherapy-related Adverse Events (irAEs) Associated with Checkpoint Inhibition for Melanoma and Other Cancers
• Deadline: October 16
  American Cancer Society RFA: The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services
• Deadline: October 16
  American Cancer Society RFA: Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families

NIH Announcements

• Deadline: August 16, 2017
  Inter-organelle Communication in Cancer (R01)
• Deadline: August 16, 2017
  Inter-organelle Communication in Cancer (R21)
• Deadline: August 17, 2017
  Tobacco Regulatory Science (R01)
• Deadline: August 17, 2017
  Tobacco Regulatory Science (R21)
• Deadline: August 17, 2017
  Tobacco Regulatory Science Small Grant Program for New Investigators (R03)
• Deadline: September 14, 2017
  Pediatric Early Phase Clinical Trials Network (UM1)
• Deadline: September 18, 2017
  Tobacco Regulatory Science Small Grant Program for New Investigators (R03)
• Deadline: September 18, 2017
  Tobacco Regulatory Science (R01)
• Deadline: September 18, 2017
  Tobacco Regulatory Science (R21)
• Deadline: October 5, 2017
  Integration of Individual Residential Histories into Cancer Research (R01)
• Deadline: October 5, 2017
  Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)
• Deadline: October 16, 2017
  Integration of Individual Residential Histories into Cancer Research (R21)
• Deadline: October 23, 2017
  Consortium Linking Oncology with Thrombosis (CLOT) (U01)
• Deadline: October 24, 2017
  Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment (U01)